title: Lysyl oxidase rs1800449 polymorphism and cancer risk among Asians: evidence from a meta-analysis and a case-control study of colorectal cancer.
abstract: Growing evidence has indicated that lysyl oxidase (LOX) G473A polymorphism (rs1800449) is associated with cancer risk among Asians. However, results of single center and small sample study lack enough power. We first investigated the effect of LOX G473A polymorphism on cancer risk among Asians by a meta-analysis, and then further validated this association by a case-control study of colorectal cancer (CRC) with LOX G473A polymorphism in a Chinese population. STATA 12.0 software was used for the meta-analysis. The relationships were evaluated by calculating the pooled odds ratios (ORs) and their 95 % confidence intervals (CIs). In a case-control study comprising 577 CRC patients and 696 controls, LOX G473A polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Logistic regression was used to evaluate genetic associations with the occurrence of CRC. The results of our meta-analysis, including seven case-control studies with a total of 2,377 cancer patients and 2,499 controls, suggested that LOX G473A polymorphism might be associated with an increased risk of cancer among Asians. In addition, results of a case-control study indicated that individuals with the AA or AG genotype had a significantly increased susceptibility to CRC occurrence, compared with individuals who had GG genotype. Overall, this meta-analysis and case-control study of CRC observed convincing association of LOX G473A polymorphism with cancer risk in Asians; our study would contribute to complete elucidation of carcinogenesis.
authors.affiliation: Department of Microbiology and Immunology, Medical College of Southeast University, Nanjing, 210009, Jiangsu, China.
authors.forename: Xueren
authors.initials: X
authors.lastname: Gao
authors.forename: Shulong
authors.initials: S
authors.lastname: Zhang
authors.forename: Zhansheng
authors.initials: Z
authors.lastname: Zhu
mesh_terms: D044466:Asian People / Q000235:genetics*; D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D008249:Protein-Lysine 6-Oxidase / Q000235:genetics*; D012307:Risk Factors
chemical_list: D008249:Protein-Lysine 6-Oxidase
references.citation: Oncogene. 2006 Apr 13;25(16):2328-38
references.pmid: 16314837
references.citation: Biotechniques. 1991 Apr;10(4):506-13
references.pmid: 1867860
references.citation: Genet Test Mol Biomarkers. 2012 Aug;16(8):915-9
references.pmid: 22533780
references.citation: Annu Rev Public Health. 2005;26:37-60
references.pmid: 15760280
references.citation: Tumour Biol. 2012 Dec;33(6):2379-83
references.pmid: 22948781
references.citation: DNA Cell Biol. 2011 Feb;30(2):111-6
references.pmid: 20929399
references.citation: J Int Med Res. 2012;40(3):917-23
references.pmid: 22906264
references.citation: Genomics. 1991 Nov;11(3):508-16
references.pmid: 1685472
references.citation: CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
references.pmid: 24399786
references.citation: Tumour Biol. 2014 Jun;35(6):5895-904
references.pmid: 24687549
references.citation: J Natl Cancer Inst. 2011 Mar 2;103(5):407-24
references.pmid: 21282564
references.citation: Cancer Biomark. 2013 Jan 1;13(6):465-70
references.pmid: 24595084
references.citation: PLoS One. 2012;7(7):e41610
references.pmid: 22911823
references.citation: APMIS. 2014 Mar;122(3):200-5
references.pmid: 23758270
references.citation: APMIS. 2011 Nov;119(11):762-8
references.pmid: 21995629